Company profile for Sentia Medical Science

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sentia is poised to be the world leader in the development of novel peptide therapeutics to manage and cure stress-related diseases by developing drugs called astressins that block the action of corticotropin releasing factor (CRF) and urocortins, the main mediators of the body’s response to stress. Astressins are designed to re-establish normal biological harmony with high efficacy and sustained effects.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3550 General Atomics Court Building G02, Room 563 San Diego, CA 92121
Telephone
Telephone
858-886-7709
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/02/14/2608117/0/en/Sentia-Medical-Sciences-and-Neurocrine-Biosciences-Extend-Research-Collaboration-to-Discover-Novel-CRF-Peptides.html

GLOBENEWSWIRE
14 Feb 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty